MgSO4 prevents left ventricular dysfunction in an animal model of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 5, 2006, Pages 1398-1403

  Coates, Brian J ^a   Broderick, Tom L ^a   Batia, Lyn M ^a   Standley, Cynthia A ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Heart; Hypertension; Magnesium; Preeclampsia; Rats

Indexed keywords

MAGNESIUM SULFATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; ENZYME INHIBITOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEART WORK; HYPERTENSION; IMPLANT; INFUSION; NONHUMAN; OSMOTIC MINIPUMP; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; HEART; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; HEART; HYPERTENSION; MAGNESIUM SULFATE; NG-NITROARGININE METHYL ESTER; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750314554     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.02.049     Document Type: Article

References (24)

1. Roberts J.M., Pearson G., Cutler J., and Lindheimer M. Summary of the NHLBI Working Group on Research in Hypertension During Pregnancy. Hyperten 41 (2003) 437-445
2. Bosio P.M., McKenna P.J., Conroy R., and O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94 (1999) 978-984
3. Abraham W.T., and Schrier R.W. Body fluid volume regulation in health and disease. Adv Intern Med 39 (1994) 23-47
4. Rubler S., Domani P.M., and Pinto E. Cardiac size and performance during pregnancy estimated with echocardiography. Am J Cardiol 40 (1977) 534
5. Simmons L.A., Gillin A.G., and Jeremy R.W. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 283 (2002) H1627-H1633
6. Visser W., and Wallenburg H.C. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 17 (1991) 1072-1077
7. Khalil R.A., Crews J.K., Novak J., Kassab S., and Granger J.P. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31 (1998) 1065-1069
8. Buhimschi I.A., Shi S.Q., Saade G.R., and Garfield R.E. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Am J Obstet Gynecol 184 (2001) 686-693
9. Molnar M., Suto T., Toth T., and Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 170 (1994) 1458-1466
10. Veille J.C., Hosenpud J.D., and Morton M.J. Cardiac size and function in pregnancy-induced hypertension. Am J Obstet Gynecol 150 (1984) 443-449
11. Sanchez R., Glenny J.E., Marco E., Voto L.S., Lapidus A.M., Iglesias G.H., et al. Two-dimensional and M-mode echocardiographic findings in hypertensive pregnant women. Am J Obstet Gynecol 154 (1986) 910-913
12. Mabie W.C., DiSessa T.G., Crocker L.G., Sibai B.M., and Arheart K.L. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 170 (1994) 849-856
13. Thatcher C.D., and Keith J.C. Pregnancy-induced hypertension: development of a model in the pregnant sheep. Am J Obstet Gynecol 155 (1986) 201-207
14. Cadnapaphornchai M.A., Ohara M., Morris G., Knotek M., Rogachev B., Ladtkow T., et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 280 (2001) F592-F598
15. Smith G.C.S., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischemic heart disease: a retrospective cohort study of 129,290 births. Lancet 257 (2001) 2002-2006
16. Jonsdottir L.S., Arngrimsson R., Geirsson R., Sigvaldason H., and Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 74 (1995) 772-776
17. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease?. Am J Cardiovasc Drugs 3 (2003) 231-239
18. Woods K.L. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 32 (1991) 3-10
19. Scardo J.A., Hogg B.B., and Newman R.B. Favorable hemodynamic effects of magnesium sulfate in preeclampsia. Am J Obstet Gynecol 173 (1995) 1249-1253
20. Smirnova I.V., Sawamura T., and Goligorsky M.S. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency. Am J Physiol Renal Physiol 287 (2004) F25-F32
21. Nishio A., Gebrewold A., Altura B.T., and Altura B.M. Comparative vasodilator effects of magnesium on rat mesenteric arterioles and venules. Arch Int Pharmacodyn Ther 298 (1989) 139-163
22. Shechter M., Sharir M., Labrador M.J.P., Forrester J., Silver B., and Merz N.B. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102 (2000) 2353-2358
23. Horner S.M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 86 (1992) 774-779
24. Christensen C.W., Rieder M.A., Silverstein E.L., and Gencheff N.E. Magnesium sulfate recudes myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 92 (1995) 2617-2621